BioSpace News Archive

Genetown

Boston Scientific Announces Upcoming Investor Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

May 1, 2024
·
1 min read
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

May 1, 2024
·
14 min read
Genetown

Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting

Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.

May 1, 2024
·
3 min read
Biotech Bay

OmniAb to Participate in Five Investor Conferences in May

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May.

May 1, 2024
·
3 min read
Alpha Tau to Participate in May 2024 Investor Conferences

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.

May 1, 2024
·
1 min read
Policy

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

Neuronetics, Inc., a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is committed to supporting adolescents facing major depressive disorder.

May 1, 2024
·
4 min read
Biotech Beach

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

Palisade Bio, Inc. announced the successful completion of its analysis to determine the effects of bioactivated PALI-2108 on TNF-α production in a whole blood assay.

May 1, 2024
·
5 min read
Lone Star Bio

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences

Genprex, Inc. today announced the Company’s participation in the following upcoming investor and industry conferences to be held in May 2024.

May 1, 2024
·
5 min read
Business

Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America

Establishment Labs Holdings Inc. announced today that Jeff Ehrhardt has joined the company as General Manager of North America.

May 1, 2024
·
7 min read
MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization

MMI (Medical Microinstruments, Inc.) today announced the completion of its first clinical cases in the United States using the Symani® Surgical System.

May 1, 2024
·
3 min read